| 标题 |
A pomalidomide-based gefitinib PROTAC degrader effectively inhibits lung cancer progression in EGFR-TKIs-acquired resistant models by targeting EGFR degradation and ETFA-mediated ATP generation |
| 网址 | |
| DOI | |
| 其它 |
期刊:Bioorganic Chemistry 作者:Liangping Li; Yongkun Li; Xuesong Ma; Pingping Li; Shulan Zeng; et al 出版日期:2025-08-09 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)